Shanghai Easy-Flow Medical Tech Co., Ltd. (“Easy-Flow™") announces that its EF-Rhine™ Peripheral Constrained Dilation Balloon Catheter ("EF-Rhine™") has been granted approval by the National Medical Products Administration (NMPA), marking a significant milestone in the company's journey.

The EF-Rhine™ is designed for balloon dilatation of lesions in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries. 

The  construction of EF-Rhine™, featuring a nitinol scaffold that subdivides the balloon into distinct segments, offers multiple benefits during dilation. This design significantly increases the contact surface area with the vessel wall, ensuring more effective and uniform dilation. Additionally, the segmented design allows for controlled dilation, minimizing the risk of vessel trauma and potential complications.

Other features of the EF-Rhine™ include its excellent passability and flexibility, which allow the balloon to navigate through narrow and tortuous lesions with ease. The balloon's rapid deflation capability, coupled with its low profile, further enhances its ease of use. Besides, EF-Rhine™ catheter has superior visibility under imaging guidance, ensuring precise positioning during procedures. 

The NMPA approval of the EF-Rhine™ is a testament to Easy-Flow™'s dedication to innovation and quality in the field of endovascular therapy. With this certification, the company is poised to offer clinicians a reliable and effective tool in the treatment of peripheral vasculature lesions, further advancing patient care and outcomes.